DHR
DHR
NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$227.33
+2.84 (+1.27%)
As of Sep 28, 9:31 PM ET ·
Analyst Consensus
Strong Buy
32
Analysts
Very High
Coverage
Buy 27 84%
Hold 5 16%
Sell 0 0%
Price Target
Analyst Price Target -30.4% upside
Low Target $107.89
Average Target $158.11
High Target $252.83
Current Price $227.33
Current
$227.33
Target
$158.11
$107.89 $158.11 avg $252.83
Scenario Analysis
Bear Case
$107.89
-52.5%
Low target
Base Case
$158.11
-30.4%
Avg target
Bull Case
$252.83
+11.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$242.80
-6.4% from high
52-Week Low
$160.93
+41.3% from low
50-Day SMA
$227.23
+0.0% vs SMA
200-Day SMA
$209.48
+8.5% vs SMA
RSI (14)
39.9
Neutral
Target vs 52W High
$158.11
-34.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 36 81% $369.21 -45.6%
DHR
Danaher Corp
 Strong Buy 32 84% $158.11 -30.4%
A
Agilent Technologies Inc
 Strong Buy 30 77% $64.69 -63.1%
IQV
Iqvia Holdings Inc
 Strong Buy 28 82% $82.96 -69.4%
WAT
Waters Corp
 Buy 31 65% $189.60 -57.2%
ILMN
Illumina Inc
 Buy 28 57% $169.36 -37.7%
MTD
Mettler-Toledo International
 Hold 19 53% $170.43 -89.0%
WST
West Pharmaceutical Services
 Strong Buy 23 91% $136.24 -63.7%